{
  "ticker": "ADN",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02966027",
  "id": "02966027",
  "pages": 2,
  "price_sensitive": false,
  "date": "20250704",
  "time": "0941",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250704/pdf/06lgjxsp17hyy3.pdf",
  "summary": "**Summary (Appendix 3Y - Change of Director\u2019s Interest Notice):**  \n- **Director:** Jean-Dominique Marie Yves Sorel  \n- **Change:** Issued **8,272,986 zero-exercise-price options** (Service Fee Options) in lieu of director fees (value: **$60,806.45**).  \n- **Date of change:** 2 July 2025.  \n- **No prior holdings.**  \n\n*No material trading or capital markets impact identified.*  \n\n*(Note: Appendix 3Y filings typically disclose director transactions but rarely affect market decisions unless accompanied by significant volume or strategic context.)*",
  "usage": {
    "prompt_tokens": 986,
    "completion_tokens": 133,
    "total_tokens": 1119,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-03T23:58:23.973431"
}